TauroPharm

We develop antimicrobial lock solutions for patients with central-venous catheters. Improving the patient’s quality of life remains our number-one priority.

Founded in 2000, TauroPharm GmbH is a German company specialising in medical devices with antimicrobial efficacy. As TauroLock™ solutions have been approved in expert guidelines, we continue to expand our international network. Our mission
TauroPharm aims to make the application of vascular access devices (VAD) easier and safer. We are developing more effective ways to prevent catheter-associated complications – ranging from blood clotting to fatal infections. Our products
We have created a range of lock solutions suitable for implanted central-venous catheters (CVC) and port systems. These products contain several ingredients to prevent catheter occlusion and catheter-related infections. Today, TauroLock™ solutions are recommended in interdisciplinary guidelines on a national and international scale. These include the ESPEN (European Society for Clinical Nutrition and Metabolism), GAVeCeLT (Italian association for long-term central-venous access devices), SFNCM (French Society of Clinical Nutrition and Metabolism), and DGfN (German Society of Nephrology). All TauroLock™ products have been investigated in clinical trials and are certified by regulatory bodies. Our sales network
As a manufacturer, TauroPharm focuses on four areas: product development, production, training, and quality management. To distribute our products, we collaborate with international partners who provide support and advice to customers in their respective countries. Our correspondents have been carefully selected and hold trust-based partnerships with healthcare professionals in nephrology, oncology, gastroenterology, intensive and palliative medicine, and home care. Our educational programmes
TauroPharm offers special training in all countries where TauroLock™ products are sold and implemented. These programmes help distributors familiarise themselves with our lock solutions and their application.

23/09/2025

How do you keep a port catheter safe and functional? What are the Dos and Don'ts to avoid complications?

💡 We have written a comprehensive guide that answers these questions. Whether you're a patient, caregiver, or nurse: This is what you should know.

Link in comments!

17/09/2025

Four days at the ESPEN Congress seemingly flew by, and we made the most of every minute! Catching up with our partners, meeting scientists and practitioners, and enjoying the beautiful city, of course.

💡 We were especially excited to get a sneak peek for two new studies:

The team of Maria C. Ocaña Pacheco and Mario Ferreyra shared their findings on the antibiofilm efficacy of 𝗧𝗮𝘂𝗿𝗼𝗟𝗼𝗰𝗸™ in PICC lines.

Stanislav Sevela and his team from Všeobecná fakultní nemocnice v Praze - VFN presented their “integrated approach” to reduce CRBSI in home parenteral nutrition (including 𝗧𝗮𝘂𝗿𝗼𝗟𝗼𝗰𝗸™!).

More insights coming soon...

𝘋ě𝘬𝘶𝘫𝘦𝘮𝘦 𝘻𝘢 𝘱𝘰𝘻𝘷á𝘯í, 𝘗𝘳𝘢𝘩𝘰! 💙

See you next time in Berlin!

11/09/2025

You can take the employee out of TauroPharm, but you can’t take the commitment for TauroPharm out of the employee...

Turns out, that was definitely the case for Friedrich Hyn! We couldn’t be happier to share that Friedrich has – once again – joined our team. 🙌

Originally, he had started his professional career at TauroPharm after graduating university. Two years later, he moved on to work as Regional Sales Executive for our German partner Tauro-Implant GmbH. Now, after several successful years in this role, he has come back to support TauroPharm as Regional Sales Manager.

💪 There’s no doubt that we will greatly benefit from his expertise and experience, not to mention his personal drive to make a real difference in patients’ lives.

Welcome back, Frieder – feels like you never left!

09/09/2025

🚀 Revolution in nutrition: That’s the motto of the 46th ESPEN Congress. It will take place in Prague this year, from 13 to 16 September. We’ll be joining the conversation, of course, to discuss how our products have revolutionised infection prevention in parenteral nutrition.

It’s always amazing to see how The European Society for Clinical Nutrition and Metabolism brings together experts from all over the world. We’re excited to meet many of them, along with our Czech representative Zuzana Mala and other international partners.

👋 Come say hi at booth no. 9!

26/08/2025

Lock your line, every time – this goes for any patient with a central-venous catheter. But how do you know what lock solution to use?

☝️ Different patients come with different needs. That’s why we have developed a range of lock solutions based on different combinations of active ingredients.

Here are some recommendations for specific cases:

❔catheters with regular blood flow (as in haemodialysis) ➡️ TauroLock™-HEP500
❔patients with frequent occlusion problems and poor flow ➡️ 2+1 protocol
❔patients with heparin intolerance, highly frequent occlusion problems, or no possibility of catheter exchange ➡️ TauroLock™-U25.000

All of our products are designed to protect patients against catheter-related complications from the very start – effective prevention instead of costly cure. Don’t wait until it’s too late!

31/07/2025

Special guests in Waldbüttelbrunn! 🇧🇭

We had the pleasure of welcoming our partner Hasan Albaqali from Union MediScience at our headquarters this week. He was accompanied by a doctor and nurse, Dr. Abdulraqeeb Abdo Hassan and Juhaina Ebrahim Al Ghaadhban.

They are representing TauroLock™ solutions in Bahrain, and doing an excellent job at that.

No matter the geographical distance – the commitment to effective prevention unites us all over the world! 🌎

24/07/2025

🌍 Working with an international team comes with many perks. One of the most important ones: We get to expand our culinary horizons! 🍴

This week, our employee D**g cooked an authentic Korean lunch for the entire TauroPharm team. Hard to believe, but it tasted even better than it looks. 🔥

Thank you, D**g, for this amazing experience! 🙏

15/07/2025

Work hard, wine hard. 🍷☀️

We had perfect weather for our dinner at Weingut am Stein last week. Not that there’s ever a bad time to drink wine in Franconia… but it certainly tastes even better with sunshine and a view. 😎

08/07/2025

Taurolidine has proven 𝘀𝗮𝗳𝗲 𝗮𝗻𝗱 (𝗰𝗼𝘀𝘁-)𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 in preventing catheter-related infections and is therefore recommended by international guidelines. (1,2)

⚠️ But infections are not the only type of catheter-related complications that might occur. Patients with vascular-access devices also need protection against occlusion.

👉 That’s why our standard lock solution contains a combination of 𝘁𝗮𝘂𝗿𝗼𝗹𝗶𝗱𝗶𝗻𝗲 𝗮𝗻𝗱 𝟰 % 𝗰𝗶𝘁𝗿𝗮𝘁𝗲 to maintain an adequate flow rate.

For patients at high risk of occlusion, we have developed two more variants with different concentrations of 𝗵𝗲𝗽𝗮𝗿𝗶𝗻 (in addition to taurolidine and citrate). Since TauroLock™-HEP500 entered the market in 2007, it has become the gold standard for haemodialysis patients. (3,4)

☝️ Last but not least, thrombosis is another serious complication that warrants prevention. That’s where TauroLock™-U25.000 comes in: With taurolidine, 4 % citrate, and 25,000 IU 𝘂𝗿𝗼𝗸𝗶𝗻𝗮𝘀𝗲, it provides the strongest protection against severe occlusion and biofilm.

Our portfolio offers a comprehensive range of lock solutions for all central-venous catheters, PICCs, and ports. Designed to make the maintenance of VADs as easy, safe, and cost-efficient as possible.

1) Vernon-Roberts et al. JPEN J Parenter Enteral Nutr 2022. DOI: 10.1002/jpen.2363
2) Pironi et al. Clin Nutr 2020. DOI: 10.1016/j.clnu.2020.03.005
3) German Society of Nephrology (DGfN) 2019.
4) Van Roeden et al. BMC Nephrology 2021. DOI: 10.1186/s12882-021-02519-3

19/06/2025

We were delighted to welcome Nguyen Huong, our partner from Vietnam, at our headquarters this week!

☀️ Of course, we made good use of the sunny weather and showed her around the beautiful city of Würzburg.

The main purpose of her visit was an in-depth workshop to discuss clinical data and best practices. 💡 Huong also gave us insight into her work in Vietnam. Recently, there were able to introduce more product variants (in addition to TauroLock™-HEP500) for other fields of application: parenteral nutrition, chemotherapy, and intensive care. 💪

Thank you to Huong (and all of our partners) for your commitment! We couldn’t do it without you. 🤝

16/06/2025

How does it feel to live with chronic illness? We talked to someone who’s seen it from both sides: Lisa is a paediatric nurse and has been dependent on parenteral nutrition for more than 10 years now.

In our interview, she shared how her diagnosis has changed her outlook on life and how she deals with everyday challenges (with the help of TauroLock™). 💪

Full article 👉 link in comments!

07/04/2025

Ciao, Padova! 🇮🇹

The Congress of the Vascular Access Society was well worth the trip (even for the gelato alone!). 🍦

Great opportunity to catch up with some old friends – including our partners from Italy and Sweden, as well as Prof. Gurkan Sengölge, a leading expert for vascular access in dialysis.

𝘈𝘥𝘥𝘪𝘰 𝘢𝘭𝘭𝘦 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢𝘻𝘪𝘰𝘯𝘪 𝘭𝘦𝘨𝘢𝘵𝘦 𝘢𝘪 𝘤𝘢𝘵𝘦𝘵𝘦𝘳𝘪! 👋

Adresse

August-Bebel-Str. 51
Waldbüttelbrunn
97297

Telefon

+499313042990

Webseite

http://www.tauropharm.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TauroPharm erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.